Clinical trials

  • BELANTAMAB MAFODOTIN for Multiple myeloma | Transplant-ineligible newly diagnosed multiple myeloma
  • Methylprednisolone for Major surgery: Robotic-assisted laparoscopic radical prostatectomy | Major peripheral vascular surgery (femoral–popliteal bypass, tibial bypass, profundaplasty) | Coronary artery bypass grafting (on-pump and off-pump) | Thoracoscopic lung resection | Laparoscopic colorectal surgery | Minimally invasive valve repair or replacement
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Post-acute sequelae of COVID-19 (Long COVID)
  • Fluorouracil for Rectal cancer
  • YL201 for Advanced solid tumors
  • Clinical trial in Retinitis pigmentosa|PDE6A-linked Retinitis Pigmentosa
  • HYDROCORTISONE for Scheduled cardiac surgery (intermediate/high risk) | Acute renal failure
  • CETUXIMAB for Recurrent metastatic head and neck squamous cell carcinoma
  • Clinical trial in IDH1-mutated malignancies | Solid tumour | Hematological malignancy
  • CLADRIBINE for Relapsing multiple sclerosis | Multiple Sclerosis
  • POZELIMAB for Paroxysmal nocturnal hemoglobinuria
  • HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN; HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN for Human papillomavirus (HPV) infection | Cervical intraepithelial neoplasia (CIN2/3) | Cervical cancer